BioSpace News Archive

EpimAb Biotherapeutics announced the appointment of Professor Mark Smyth to the company’s Scientific Advisory Board. Currently a Senior Scientist and the Immunology Department Coordinator at QIMR Berghofer Medical Research Institute, Professor Smyth brings over 20 years of immuno-oncology expertise and research experience to the Scientific Advisory Board.

The telehealth market is riding on the wave of growth. This is because telehealth is no longer an option, but a necessity due to the increasing dangers of COVID-19.

Mobile technology has expanded significantly across the globe in recent years.

According to Transparency Market Research’s latest report on the global Implantable Medical Devices market for the historical period 2017–2018 and forecast period 2019–2027.

Digital health refers to the utilization of electronic communication or information technology-based processes, tools, and services to facilitate better healthcare services.

Aptorum Group Limited, a biopharmaceutical company focusing on the development of novel therapeutics to address global unmet medical needs, is pleased to announce that its Class A Ordinary Shares has commenced trading on the Professional Compartment of Euronext in Paris under the Euronext ticker symbol “APM” and ISIN Code: KYG6096M1069.

Getinge announces its intention to become a CO₂neutral company by 2025. The target will be reached by a stepwise approach in several areas and supports the company’s objective to contribute to a sustainable health care environmentally as well as socially.

Aleafia Health Inc. announced that Janssen Pharmaceuticals, Inc., has approved its wholly owned subsidiary, Canabo Medical Inc. as an administrator and prescriber of antidepressant SPRAVATO® nasal spray.

- If Approved, ARIKAYCE Will Be First and Only Therapy in the European Union for This Difficult-to-Treat Condition - - Decision from European Commission Expected Second Half of 2020 -

Ikonopedia announced today that Intermountain Healthcare, based in Salt Lake City, Utah , has selected the company’s structured breast reporting and risk assessment tools to help improve reporting quality, efficiency, and maintain patient safety. The system-wide implementation will be initiated at six Intermountain Healthca